GlaxoSmithKline Ebola vaccine candidate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GlaxoSmithKline Ebola vaccine candidate, covering 2018-01-04 to 2018-01-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults [Phase 2]